Health + Behavior

Researchers will look to identify genetic and environmental factors that determine how fast an individual’s Parkinson’s disease progresses.

The findings may help explain sex differences in heart disease and support the development of more personalized treatments.

The study's findings could ease concerns that the expansion of telemedicine would trigger spikes in usage and costs

College students with anxiety, depression and eating disorders benefit from therapy offered via a digital app.

At UCLA, Dr. David Nathanson is designing new therapies that tackle glioblastoma’s unique tumor biology, aiming to overcome long-standing treatment challenges.

The nasal spray has been effective at preventing or reducing severe COVID in mice and other airborne viral diseases.

Natural selection began favoring Indigenous Andeans with a high number of salivary amylase genes when potatoes were first grown in the Andean highlands.

The molecular atlas of the Down syndrome brain uncovers unexpected shifts in prenatal neuron development.

Christian Gerard Capuno will represent UCLA April 22 in the UC-wide showcase of graduate research.

Clinical trial yields insights about the role of chemotherapy, inflammation and trial design that could help shape next-gen curative therapies.

The analysis of nearly 94,000 participants in UCLA’s ATLAS Biobank highlights the value of genetic diversity in developing precision health strategies.

A UCLA-led team has developed a tougher, higher-sensitivity wearable platform for continuous monitoring of important molecules.

Experts explore how the horrifying legacy of German doctors in the Third Reich can inform ethical medical practices today.

Using large language models to analyze emergency response may offer opportunities for early intervention, a UCLA-led study finds.

In an alternate world, UCLA professor Anne Andrews might be a CIA agent. But in this one, she’s a scientist breaking new ground measuring chemicals in the brain and body.

The test could offer a more affordable approach to early disease detection.

The Ballmer Group investment will support academic and clinical training that will bring more Bruin practitioners into local communities.

California Health Interview Survey shows disparities by race and ethnicity, gender, disability and other categories.

All the children treated in a clinical trial are living with restored immune function.

After years of hospital stays and fear, families are watching their kids thrive. Today, the gene therapy they received earned accelerated approval from the FDA.

The gift is being made in memory of their son Brandon, who received his bachelor’s in aerospace engineering from UCLA in 2014.

A study co-authored by UCLA researchers suggests certain chemical compounds correlated with lower newborn health scores.

The advance could lead to safer, more effective T cell therapies for prostate cancer and other solid tumors.

Peer-reviewed studies show diabetes and other illnesses can stem from the combination of long work hours and poor eating habits.

CAR-NKT cell therapy can be produced at a fraction of the cost of personalized treatments.